Milrinone or dobutamine in patients with heart failure: evidence from meta‐analysis
Saved in:
Main Authors: | Lukasz Szarpak, Piotr Szwed, Aleksandra Gasecka, Zubaid Rafique, Michal Pruc, Krzysztof J. Filipiak, Milosz J. Jaguszewski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | ESC Heart Failure |
Online Access: | https://doi.org/10.1002/ehf2.13812 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ivabradine and Milrinone—Bridge to Recovery in New HFrEF With Low-Output Heart Failure
by: Lekha Racharla, et al.
Published: (2024-01-01) -
Acute Heart Failure Exacerbation with Cardiogenic Shock and Elevated Systemic Vascular Resistance Treated with a Combination of Nicardipine and Dobutamine Therapy
by: Lydia E. Issac, et al.
Published: (2017-01-01) -
STEMI after Dobutamine Stress Echocardiography in Hyperthyroid State
by: Mahmood Mubasher, et al.
Published: (2019-01-01) -
Comparison of Milrinone with Sildenafil for the Treatment of Persistent Pulmonary Hypertension of the Newborn
by: Imtiaz Ahmad, et al.
Published: (2024-06-01) -
Inhaled milrinone for the management of severe pulmonary hypertension in non-cardiac surgery
by: Philip Stamov, et al.
Published: (2024-11-01)